Peer Review Process
Mathews Open Access Journals follows double blind peer review process. In this we do not reveal author names, affiliations to the reviewer and vice versa. We adhere to the Committee on Publication Ethics (COPE), code of conduct, and best practice guidelines (http://publicationethics.org). We strive to ensure that the peer review is fair, unbiased and timely. Decisions to accept or reject a manuscript for publication in the journal are based on the manuscript’s importance, originality, clarity, and the study’s validity and its relevance to remit of the journal. The process also involves strictly no plagiarism or fabrication of the data and parallel submissions.
Responsibilities
Being a reviewer you are accountable to take the responsibility of maintaining confidentiality of ideas that have been presented in the papers assigned to review. Focus your evaluation on merits and demerits of the article; assess the correctness, accuracy, clarity, and innovation of the research. Never reveal the assigned paper's results or videos/images or any of the supplementary material to non-reviewers.
The reviewers are given ample time for the review and submission of comments to the editorial office. Reviewers’ evaluations play a major role in our decision as to whether to accept a manuscript for publication.
Ethical Issues
Published : 20th February 2025
Authors : Ezegbe Chekwube Andrew1,3,*, Anikwe Chidera Celestine4, Ezegbe Amarachi Grace2,#, Okafor Nnedimma Pauline1, Odo Kenechi Benjamin1, Onyia Oluebube Chisom1, Agu-kalu Amarachi1, Ugorji Anita Chidera1, Uchenna Chiamaka Precious1, Onoduagu Simeon Chinedu1, Dingwoke Juliet Obianuju1, Onyekwere Favour Ezinne1
Citation : Andrew EC, et al. (2025). Mucoadhesive Polymer-Based Formulations for Drug Delivery. Mathews J Pharma Sci. 9(1):44.
Published : 31st January 2025
Authors : Ferruccio Trifirò1,*, Paolo Zanirato2,#
Citation : Trifirò, et al. (2025). Recent ECHA and POP Restrictions On the Use of Substances from the PFAS Family. Mathews J Pharma Sci. 9(1):42.
Published : 28th January 2025
Authors : B Ravindra Babu*, Mammai Pranitha
Citation : Ravindra Babu B, et al. (2025). Formulation and Evaluation of Solid Lipid Nanoparticles Loaded with Orlistat for Enhanced Oral Bioavailability. Mathews J Pharma Sci. 9(1):43.
Published : 09th January 2025
Authors : Anikwe Chidera Celestine1,2, Ezegbe Chekwube Andrew3,4,*, Ugwu Emmanuel Oforma1, Ogbozor Maduaburochi Christian1, Ozioko Diana Chinenyenwa1, Eneje Jude Chetachukwu1, Ugorji Anita Chidera4, Uchenna Chiamaka Precious4, Onyekwere Favour Ezinne4, Odo Kenechi Benjamin4, Ezugwu Christopher Obodike1
Citation : Celestine AC, et al. (2025). Investigation into the Pharmacognostic and Antimicrobial Properties of the Leaf Extract of Bridelia Ferruginea Benth (Euphorbiaceae). Mathews J Pharma Sci. 9(1):41.
Published : 14th December 2024
Authors : Mohammad Nadeem khan*
Citation : Khan MN. (2024). Cyclotron Technology: Revolutionizing Nuclear Medicine for Geriatric Disorders. Mathews J Pharma Sci. 8(4):43.
Published : 30th November 2024
Authors : Ferruccio Trifirò1, Paolo Zanirato2,*
Citation : Trifirò F, et al. (2024). Water Purification: Physical, Mechanical, Chemical and Biological Treatments. Mathews J Pharma Sci. 8(3):42.